Ligand Pharmaceuticals Incorporated Development Agreements

4 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment No. 2 to Development Funding and Royalties Agreement, dated as of November 29, 2023, by and between the Company and Palvella Therapeutics, Inc
Development Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
NY
2024
Amendment No. 1 to Development Funding and Royalties Agreement, dated as of May 22, 2020, by and between the Company and Palvella Therapeutics, Inc
Development Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
2024
Development Funding and Royalties Agreement, dated December 13, 2018, by and between Ligand Pharmaceuticals Incorporated and Palvella Therapeutics, Inc
Development Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
NY
2019
AMENDMENT NO. 2 TO PRODUCT DEVELOPMENT AND COMMERCIALIZATION AGREEMENT
Development Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
DE
2009